Improved cancer survival in the Northern Territory: identifying progress and disparities for Aboriginal peoples, 1991–2020
Medical Journal of Australia · 2025
DOI: 10.5694/mja2.52656 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Journal of Australia, 2025. Verfasst von Rowena Boyd und 6 weiteren Autor:innen. Beteiligte Einrichtung: Northern Territory Department of Health, Darwin, NT. Hauptthemen laut MEDLINE: Neoplasms, Healthcare Disparities. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Objectives
To investigate cancer survival for Aboriginal and non‐Aboriginal peoples in the Northern Territory during the period 1991–2020, across the 15 most prevalent primary cancer sites. Study design Retrospective cohort study of Northern Territory Cancer Registry notifications. Setting, participants NT residents diagnosed with an invasive cancer from 1 January 1991 to 31 December 2020. Main outcome measures Five‐year survival for all cancers and for 15 primary cancer sites by 10‐year periods of diagnosis, and excess hazard ratios comparing excess mortality following cancer diagnosis for Aboriginal peoples compared with non‐Aboriginal peoples.
Results
Of 17 759 cancer registrations analysed, 3350 (18.9%) had Indigenous status recorded as Aboriginal. Five‐year survival improved significantly from 1991–2000 to 2011–2020 for all populations, including Aboriginal (males, 20.5% to 37.1%; females, 32.3% to 47.2%) and non‐Aboriginal (males, 50.0% to 65.9%; females, 64.5% to 75.4%). The gap in 5‐year cancer survival for Aboriginal peoples closed by 12.4% (4.0 percentage difference) for females, but only by 2.4% (0.7 percentage difference) for males. For all 15 cancer sites, 5‐year survival improved, but Aboriginal peoples experienced excess mortality, ranging from an excess hazard ratio of 1.3 for mortality following diagnosis of liver cancer to 6.1 for prostate cancer during the period 2011–2020.
Conclusions
Cancer survival has improved for Aboriginal and non‐Aboriginal peoples in the NT. However, the gap in survival outcomes for Aboriginal peoples persists. Further research is required on pathways to close the gap, including: improving access to care, understanding social and cultural factors, reducing diagnostic and treatment delays, and promoting greater equity of Aboriginal participation in clinical trials. Quality improvement approaches led by Aboriginal peoples should be prioritised to tailor culturally appropriate preventive strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Northern Territory Department of Health, Darwin, NT.
- Royal Darwin Hospital, Darwin, NT.
- Charles Darwin University, Darwin, NT.
ORCID-Profile: C Paul Burgess
Zitieren
APA
Boyd, R., Charakidis, M., Burgess, C. P., Dugdale, S., Castillon Jawoyn Katherine Region Nt, C., Sutandar, D., & Wright, A. (2025). Improved cancer survival in the Northern Territory: identifying progress and disparities for Aboriginal peoples, 1991–2020. Medical Journal of Australia. https://doi.org/10.5694/mja2.52656
Vancouver
Boyd R, Charakidis M, Burgess CP, Dugdale S, Castillon Jawoyn Katherine Region Nt C, Sutandar D, et al. Improved cancer survival in the Northern Territory: identifying progress and disparities for Aboriginal peoples, 1991–2020. Medical Journal of Australia. 2025. doi:10.5694/mja2.52656
BibTeX
@article{Boyd2025,
author = {Boyd, Rowena and Charakidis, Michail and Burgess, C Paul and Dugdale, Sarah and Castillon Jawoyn Katherine Region Nt, Craig and Sutandar, Dzulfikaar and Wright, Alyson},
title = {Improved cancer survival in the Northern Territory: identifying progress and disparities for Aboriginal peoples, 1991–2020},
journal = {Medical Journal of Australia},
year = {2025},
doi = {10.5694/mja2.52656}
}
EUVIMED